SCHEMBL474394

SCHEMBL474394

COC(=O)c1ccc(-c2ccccc2)c(C(C)C(O)(c2ccc3c(c2)N(C)C(=O)CO3)C(F)(F)F)c1

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PTGER3 P43115 1/20 0.35
USP30 Q70CQ3 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPK14 Q16539 3/20 0.34
EGFR P00533 1/20 0.34
GPR55 Q9Y2T6 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
PTGS2 P35354 1/20 0.34
HSD17B10 Q99714 1/20 0.33
PDK2 Q15119 1/20 0.32
CASP3 P42574 1/20 0.32
MALT1 Q9UDY8 1/20 0.32
THRB P10828 1/20 0.32
PDE3B Q13370 1/20 0.32
PDE3A Q14432 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL473958 0.92 ALDH1A1 (0.37) POLBPTGER3USP30ALDH1A1GPR55
SCHEMBL474476 0.88 MAPK14 (0.35) POLBSMN1; SMN2PTGER3USP30MAPK14
SCHEMBL474611 0.88 SMN1; SMN2 (0.35) POLBSMN1; SMN2ALDH1A1MAPK14EGFR
SCHEMBL474658 0.85 SMN1; SMN2 (0.36) POLBSMN1; SMN2ALDH1A1MAPK14EGFR
SCHEMBL474431 0.84 TRPV1 (0.41) POLBALDH1A1CASP3
SCHEMBL474384 0.83 GPR55 (0.36) POLBSMN1; SMN2PTGER3USP30MAPK14
SCHEMBL12163834 0.83 GPR55 (0.36) POLBSMN1; SMN2PTGER3USP30MAPK14
SCHEMBL473989 0.82 ALDH1A1 (0.37) POLBPTGER3ALDH1A1GPR55L3MBTL1
SCHEMBL474455 0.80 ALDH1A1 (0.34) ALDH1A1MALT1
SCHEMBL474720 0.79 PTGER3 (0.33) POLBSMN1; SMN2PTGER3USP30ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2411365-A1 2,3-DIARYL- OR HETEROARYL-SUBSTITUTED 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2012-02-01 EP disclosed